COM:REVMED
Revolution Medicines
- Stock
Last Close
57.07
21/11 21:00
Market Cap
7.01B
Beta: -
Volume Today
864.68K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -31.13M - | -41.79M 34.25% | -47.66M 14.06% | -108.16M 126.92% | -187.09M 72.98% | -248.71M 32.93% | -436.37M 75.46% | |
depreciation and amortization | 1.19M - | 1.76M 48.48% | 3.34M 89.46% | 6.54M 95.84% | 7.33M 12.02% | 9.66M 31.70% | 9.31M 3.59% | |
deferred income tax | 201K - | -4.37M 2,275.62% | -375K 91.42% | -419K - | -3.91M 833.17% | |||
stock based compensation | 141K - | 855K 506.38% | 3.16M 269.71% | 8.89M 181.11% | 20.72M 133.22% | 31.20M 50.53% | 61.77M 98.01% | |
change in working capital | 4.65M - | 38.06M 718.52% | -8.83M 123.19% | -8.30M 5.94% | 8.72M 205.06% | -13.49M 254.62% | 40.66M 401.45% | |
accounts receivables | -1.43M - | 2.34M 263.46% | 464K 80.20% | 1.26M 170.69% | 3.42M 172.21% | |||
inventory | 1.43M - | -2.34M 263.46% | 7.68M 427.73% | |||||
accounts payables | 1.97M - | 109K 94.46% | 5.26M 4,729.36% | 305K 94.21% | 2.24M 634.10% | 7.29M 225.50% | 32.47M 345.51% | |
other working capital | 2.68M - | 37.95M 1,315.06% | -14.09M 137.13% | -8.61M 38.91% | -1.66M 80.71% | -22.03M 1,226.49% | 4.77M 121.67% | |
other non cash items | 2.12M - | 4.75M 123.76% | 1.34M 71.70% | 3.13M 133.13% | -2.64M 184.32% | -22.04M 734.77% | ||
net cash provided by operating activities | -25.15M - | 1.21M 104.82% | -49.62M 4,190.35% | -100.06M 101.68% | -147.18M 47.09% | -224.40M 52.47% | -350.57M 56.23% | |
investments in property plant and equipment | -1.57M - | -1.50M 4.83% | -2.59M 72.72% | -2.93M 13.29% | -6.53M 122.57% | -10.82M 65.69% | -7.73M 28.54% | |
acquisitions net | 160K - | 196K 22.50% | 231.30M 117,910.20% | 135.59M 41.38% | 13.30M 90.19% | 840.83M 6,222.06% | ||
purchases of investments | -172.27M - | -544.13M 215.87% | -671.34M 23.38% | -612.77M 8.72% | -1.06B 72.81% | |||
sales maturities of investments | 66.69M - | 312.83M 369.09% | 535.75M 71.26% | 599.47M 11.89% | 724.05M 20.78% | |||
other investing activites | 6M - | -231.30M 3,955.00% | -135.59M 41.38% | -13.30M 90.19% | -840.83M 6,222.06% | |||
net cash used for investing activites | -1.57M - | -1.34M 14.98% | -101.97M 7,515.31% | -234.23M 129.71% | -142.12M 39.33% | -24.12M 83.03% | -342.60M 1,320.63% | |
debt repayment | ||||||||
common stock issued | 74K - | 420K 467.57% | 100.03M 23,716.19% | 420.07M 319.95% | 291.24M 30.67% | 298.05M 2.34% | 392.39M 31.66% | |
common stock repurchased | -45K - | 832K 1,948.89% | 1.88M 125.36% | 1.86M 0.59% | 3.32M 77.95% | |||
dividends paid | ||||||||
other financing activites | 22.59M - | 60.43M 167.52% | -1.32M 102.19% | 1.88M 241.66% | 1.06M 43.37% | 1.52M 43.27% | 833.49M 54,626.92% | |
net cash used provided by financing activities | 22.66M - | 60.85M 168.50% | 98.66M 62.14% | 422.78M 328.53% | 294.18M 30.42% | 301.43M 2.47% | 1.23B 307.79% | |
effect of forex changes on cash | -1.29M - | |||||||
net change in cash | -4.06M - | 60.72M 1,595.22% | -52.93M 187.16% | 88.48M 267.17% | 4.88M 94.48% | 52.91M 983.88% | 534.74M 910.56% | |
cash at beginning of period | 13.14M - | 9.08M 30.91% | 69.80M 668.81% | 16.87M 75.83% | 105.35M 524.38% | 110.23M 4.63% | 161.41M 46.43% | |
cash at end of period | 9.08M - | 69.80M 668.81% | 16.87M 75.83% | 105.35M 524.38% | 110.23M 4.63% | 163.15M 48.00% | 696.15M 326.69% | |
operating cash flow | -25.15M - | 1.21M 104.82% | -49.62M 4,190.35% | -100.06M 101.68% | -147.18M 47.09% | -224.40M 52.47% | -350.57M 56.23% | |
capital expenditure | -1.57M - | -1.50M 4.83% | -2.59M 72.72% | -2.93M 13.29% | -6.53M 122.57% | -10.82M 65.69% | -7.73M 28.54% | |
free cash flow | -26.72M - | -286K 98.93% | -52.20M 18,153.50% | -103.00M 97.29% | -153.71M 49.24% | -235.22M 53.03% | -358.30M 52.33% |
All numbers in (except ratios and percentages)